Design and synthesis of novel bis(l-amino acid) ester prodrugs of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) with improved anti-HBV activity
作者:Xiaozhong Fu、Saihong Jiang、Chuan Li、Jian Xin、Yushe Yang、Ruyun Ji
DOI:10.1016/j.bmcl.2006.10.021
日期:2007.1
A series of novel bis(L-amino acid) ester prodrugs of 9-[2-(phosphonomethoxy)ethyl] adenine (PMEA) was synthesized and their anti-HBV activity was evaluated in HepG 2 2.2.15 cells. Compounds 11, 12, 21, 22, 26, and 27 demonstrated more potent anti-HBV activity and higher selective index (SI) than adefovir dipivoxil, which was used as a positive control. Compound 11, which was found to be the most potent
合成了一系列新型的9- [2-(膦酰基甲氧基)乙基]腺嘌呤(PMEA)双(L-氨基酸)酯前药,并在HepG 2 2.2.15细胞中评估了它们的抗HBV活性。与用作阳性对照的阿德福韦酯相比,化合物11、12、21、22、26和27表现出更强的抗HBV活性和更高的选择性指数(SI)。被发现是最有效的化合物11,其效力是阿德福韦酯的5倍,EC50值为0.095 microM,CC50值为6636 microM。化合物11的SI值(> 69,000)分别比阿德福韦酯和拉米夫定高60倍和24倍。体外稳定性研究表明,化合物11比阿德福韦酯更稳定,t1 / 2为270分钟。